Articles from BIOTECH Patent News (April 1, 2001)

1-36 out of 36 article(s)

Title	Type	Words
[1] Incyte obtains United States patent.	Brief Article	38
Abgenix obtains United States patent.	Brief Article	34
Aurora announces issuance of second patent on fluorescence assay technology.	Brief Article	322
Avigen granted gene therapy patent for intravenous delivery of Aav vectors.	Brief Article	487
Baxter Healthcare and Genetics Institute announce settlement.	Brief Article	147
DeKalb Genetics obtains United States patent.	Brief Article	39
Entremed reports on tissue factor pathway inhibitor as an antiangiogenic agent.	Brief Article	389
EpiGenesis and Hybridon to collaborate on antisense for respiratory diseases.	Brief Article	439
Evotec OAI signs screening technology agreement with Celltech.	Brief Article	336
Federal lawsuit against Empyrean Bioscience dismissed.	Brief Article	206
Harvard obtains United States patent.	Brief Article	25
Hybridon obtains second generation ribozyme patent.	Brief Article	175
Incyte obtains United States patent.	Brief Article	48
Institut Pasteur obtains United States patent.	Brief Article	58
Iowa State University obtains United States patent.	Brief Article	27
Kirin Brewery obtains United States patent.	Brief Article	38
Lexicon Genetics announces issuance of two key gene trapping patents.	Brief Article	390
Lexicon Genetics announces major scale-up of gene knockout program.	Brief Article	622
London High Court issues ruling in erythropoietin patent litigation.	Brief Article	225
Merck licenses gene expression data microarray technology from Incyte.	Brief Article	258
Millennium and BZL Biologics agree to develop antibodies against prostate cancer.	Brief Article	1151
Myriad Genetics obtains United States patent.	Brief Article	43
Neotherapeutics receives patent for bifunctional molecule technology platform.	Brief Article	205
Pioneer Hi-Bred obtains United States patent.	Brief Article	54
Powderject DNA vaccine achieves protective immunity.	Brief Article	850
Rockefeller obtains United States patent.	Brief Article	42
Salk Institute obtains United States patent.	Brief Article	45
Seikagaku Kogyo obtains United States patent.	Brief Article	35
Smithkline Beecham obtains United States patent.	Brief Article	40
University of Maryland obtains United States patent.	Brief Article	41
Valentis clinical trial of an intravenous IL-2 gene medicine for lung cancer is underway.	Brief Article	361
Valentis files suit against Alza for patent infringement.	Brief Article	273
Valentis licenses technology to Glaxo-smithkline for functional genomics research.	Brief Article	298
Vical announces issuance of key naked DNA vaccine patent.	Brief Article	281
Yeda Research & Development obtains United States patent.	Brief Article	32
ZYCOS' lead drug awarded second patent for treatment of HPV infections.	Brief Article	245